Merck & Co. ROE Ratio 2011-2026 | MRK

Annual ROE Ratio Merck & Co.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
34.7	36.96	0.97	31.52	34.11	27.82	37.99	23.3	6.97	9.78	9.94	24.5	8.85	11.63	11.5

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
37.99	0.97	20.7

Quarterly ROE Ratio Merck & Co.

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
37.79	39.13	41.87	42.85	20.34	13.86	9.38	5.18	29.71	26.92	39.66	45.1	40.63	29.17	40.79	39.67	46.89	36.19	43.53	39.25	37.7	28.9	36.2	36.16	32.25	16.45	16.29	8.82	8.1	10.02	15.47	21.08	18.42	11.26	15.35	13.99	12.52	7.76	9.6	7.35	9.93	9.46	11.72	12.14	9.84	7.28	10.54	11.54	13.1	9.92	13.02	12.87	13.2	8.73	3.1	3.71	1.91

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
46.89	1.91	20.94

ROE Ratio of other stocks in the Biotechnology industry

Issuer	ROE Ratio	Price	% 24h	Market Cap	Country
Applied Genetic Technologies Corporation AGTC	-62.37	-	-	$ 26.5 M	USA
MorphoSys AG MOR	15.76	-	2.43 %	$ 254 M	Germany
Allakos ALLK	-110.0	-	-	$ 28.6 M	USA
Advaxis ADXS	196.88	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	-37.09	-	0.23 %	$ 488 M	USA
AlloVir ALVR	-55.11	-	4.14 %	$ 49.1 M	USA
I-Mab IMAB	-85.31	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	-21.7	-	-	$ 1.01 B	USA
Ampio Pharmaceuticals AMPE	-256.9	-	-11.43 %	$ 502 K	USA
Midatech Pharma plc MTP	-330.29	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	5.18	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	-5.9	$ 0.88	-2.07 %	$ 6.47 M	China
Biophytis SA BPTS	-751.94	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	626.29	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	30.9	$ 22.67	1.66 %	$ 3.76 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	-115.61	-	-1.52 %	$ 24.7 M	USA
Applied Molecular Transport AMTI	-207.64	-	-	$ 10.1 M	USA
AIkido Pharma AIKI	-32.34	-	1.93 %	$ 17.4 M	USA
Applied Therapeutics APLT	698.49	-	-	$ 8.42 M	USA
Aptinyx APTX	-169.38	-	-39.0 %	$ 4.57 M	USA
Avenue Therapeutics ATXI	-158.79	-	-52.27 %	$ 4.45 M	USA
Институт стволовых клеток человека ISKJ	17.55	-	-	-	Russia
Aeterna Zentaris AEZS	-401.79	-	5.93 %	$ 314 M	Canada
Ayala Pharmaceuticals AYLA	3458.87	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	51843.24	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	-716.17	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	125.33	-	17.91 %	$ 11.1 M	USA
Atreca BCEL	-123.92	-	-11.76 %	$ 5.79 M	USA
Brainstorm Cell Therapeutics BCLI	103.22	-	-2.5 %	$ 5.88 M	USA
BioNTech SE BNTX	1.11	$ 102.06	-	$ 27.2 B	Germany
BioDelivery Sciences International BDSI	45.18	-	-4.8 %	$ 255 M	USA
Aquestive Therapeutics AQST	248.9	$ 4.09	-0.24 %	$ 437 M	USA
Arcutis Biotherapeutics ARQT	-8.52	$ 23.29	-0.56 %	$ 2.96 B	USA
Autolus Therapeutics plc AUTL	-161.42	$ 1.48	4.23 %	$ 394 M	Britain
Aptose Biosciences APTO	93.75	-	-45.71 %	$ 1.2 M	Canada
AstraZeneca PLC AZN	20.44	-	-	$ 96.9 B	Britain
AVROBIO AVRO	12.83	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	-175.75	$ 2.91	0.34 %	$ 4.79 M	Israel
BeiGene, Ltd. BGNE	6.58	-	0.49 %	$ 251 B	Cayman-islands
Akero Therapeutics AKRO	-33.6	-	-	$ 3.67 B	USA
Evogene Ltd. EVGN	-41.09	$ 0.79	1.28 %	$ 27.9 M	Israel
CureVac N.V. CVAC	-59.8	-	-	$ 867 M	Germany
bluebird bio BLUE	-108.93	-	-	$ 546 M	USA
Cara Therapeutics CARA	-86.96	-	-3.03 %	$ 260 M	USA
CASI Pharmaceuticals CASI	-43.38	-	-	$ 35.4 M	USA
BioXcel Therapeutics BTAI	73.22	$ 1.06	-2.75 %	$ 12.9 M	USA
ChemoCentryx CCXI	-46.05	-	-	$ 3.74 B	USA
Cabaletta Bio CABA	-149.8	$ 2.86	-1.72 %	$ 287 M	USA
Cidara Therapeutics CDTX	-103.99	-	-	$ 1.41 B	USA
Allena Pharmaceuticals ALNA	-257.91	-	3.16 %	$ 1.9 M	USA